Advertisement
Screener

KALA BIO, INC. (KALA) Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3

1.4 / 5 stars · 16/59 Roast Me

KALA BIO, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3

KALA BIO, INC. (KALA) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.

Financial Statements › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net

us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3 · last filed 2026-04-15

  • KALA BIO, INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for the quarter ending 2025-12-31 was $0.00.
  • KALA BIO, INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for the quarter ending 2025-09-30 was $0.00.
  • KALA BIO, INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for the quarter ending 2025-06-30 was $0.00.
  • KALA BIO, INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for the quarter ending 2025-03-31 was $0.00.
  • KALA BIO, INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for fiscal 2025 was $0.00.
  • KALA BIO, INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for fiscal 2024 was $0.00.
  • KALA BIO, INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for fiscal 2023 was $0.00.
  • KALA BIO, INC. fair value, measurement with unobservable inputs reconciliation, liability, transfers into level 3 for fiscal 2022 was $0.00.
Period endFair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 3 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 6 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 9 monthFair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers Into Level 3 12 month
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15
$0.00
derived: sum of 2 quarters · filed 2026-04-15
$0.00
derived: sum of 3 quarters · filed 2026-04-15
$0.00
10-K · filed 2026-04-15
2025-09-30$0.00
10-Q · filed 2025-11-19
$0.00
derived: sum of 2 quarters · filed 2025-11-19
$0.00
10-Q · filed 2025-11-19
$0.00
derived: sum of 4 quarters · filed 2026-04-15
2025-06-30$0.00
10-Q · filed 2025-08-08
$0.00
10-Q · filed 2025-08-08
$0.00
derived: sum of 3 quarters · filed 2026-04-15
$0.00
derived: sum of 4 quarters · filed 2026-04-15
2025-03-31$0.00
10-Q · filed 2025-05-14
$0.00
derived: sum of 2 quarters · filed 2026-04-15
$0.00
derived: sum of 3 quarters · filed 2026-04-15
$0.00
derived: sum of 4 quarters · filed 2026-04-15
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15
$0.00
derived: sum of 2 quarters · filed 2026-04-15
$0.00
derived: sum of 3 quarters · filed 2026-04-15
$0.00
10-K · filed 2026-04-15
2024-09-30$0.00
10-Q · filed 2024-11-12
$0.00
derived: sum of 2 quarters · filed 2024-11-12
$0.00
10-Q · filed 2024-11-12
$0.00
derived: sum of 4 quarters · filed 2025-03-31
2024-06-30$0.00
10-Q · filed 2024-08-06
$0.00
10-Q · filed 2024-08-06
$0.00
derived: sum of 3 quarters · filed 2025-03-31
$0.00
derived: sum of 4 quarters · filed 2025-03-31
2024-03-31$0.00
10-Q · filed 2024-05-14
$0.00
derived: sum of 2 quarters · filed 2025-03-31
$0.00
derived: sum of 3 quarters · filed 2025-03-31
$0.00
derived: sum of 4 quarters · filed 2025-03-31
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
$0.00
derived: sum of 2 quarters · filed 2025-03-31
$0.00
derived: sum of 3 quarters · filed 2025-03-31
$0.00
10-K · filed 2025-03-31
2023-09-30$0.00
10-Q · filed 2023-11-13
$0.00
derived: sum of 2 quarters · filed 2023-11-13
$0.00
10-Q · filed 2023-11-13
$0.00
derived: sum of 4 quarters · filed 2024-03-29
2023-06-30$0.00
10-Q · filed 2023-08-04
$0.00
10-Q · filed 2023-08-04
$0.00
derived: sum of 3 quarters · filed 2024-03-29
$0.00
derived: sum of 4 quarters · filed 2024-03-29
2023-03-31$0.00
10-Q · filed 2023-05-09
$0.00
derived: sum of 2 quarters · filed 2024-03-29
$0.00
derived: sum of 3 quarters · filed 2024-03-29
$0.00
derived: sum of 4 quarters · filed 2024-03-29
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29
$0.00
derived: sum of 2 quarters · filed 2024-03-29
$0.00
derived: sum of 3 quarters · filed 2024-03-29
$0.00
10-K · filed 2024-03-29
2022-09-30$0.00
10-Q · filed 2022-11-08
$0.00
derived: sum of 2 quarters · filed 2022-11-08
$0.00
10-Q · filed 2022-11-08
$0.00
derived: sum of 4 quarters · filed 2023-03-03
2022-06-30$0.00
10-Q · filed 2022-08-11
$0.00
10-Q · filed 2022-08-11
$0.00
derived: sum of 3 quarters · filed 2023-03-03
$0.00
derived: sum of 4 quarters · filed 2023-03-03
2022-03-31$0.00
10-Q · filed 2022-05-16
$0.00
derived: sum of 2 quarters · filed 2023-03-03
$0.00
derived: sum of 3 quarters · filed 2023-03-03
$0.00
derived: sum of 4 quarters · filed 2023-03-03
2021-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03
$0.00
derived: sum of 2 quarters · filed 2023-03-03
$0.00
derived: sum of 3 quarters · filed 2023-03-03
$0.00
10-K · filed 2023-03-03
2021-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15
$0.00
derived: sum of 2 quarters · filed 2021-11-15
$0.00
10-Q · filed 2021-11-15
$0.00
derived: sum of 4 quarters · filed 2022-03-29
2021-06-30$0.00
10-Q · filed 2021-08-05
$0.00
10-Q · filed 2021-08-05
$0.00
derived: sum of 3 quarters · filed 2022-03-29
$0.00
derived: sum of 4 quarters · filed 2022-03-29
2021-03-31$0.00
10-Q · filed 2021-05-05
$0.00
derived: sum of 2 quarters · filed 2022-03-29
$0.00
derived: sum of 3 quarters · filed 2022-03-29
$0.00
derived: sum of 4 quarters · filed 2022-03-29
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29
$0.00
derived: sum of 2 quarters · filed 2022-03-29
$0.00
derived: sum of 3 quarters · filed 2022-03-29
$0.00
10-K · filed 2022-03-29
2020-09-30$0.00
10-Q · filed 2020-11-05
$0.00
derived: sum of 2 quarters · filed 2020-11-05
$0.00
10-Q · filed 2020-11-05
2020-06-30$0.00
10-Q · filed 2020-08-06
$0.00
10-Q · filed 2020-08-06
2019-12-31$0.00
10-K · filed 2020-02-12
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12
$0.00
derived: sum of 2 quarters · filed 2020-02-12
$0.00
derived: sum of 3 quarters · filed 2020-02-12
$0.00
10-K · filed 2020-02-12
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$0.00
derived: sum of 2 quarters · filed 2018-11-08
$0.00
10-Q · filed 2018-11-08
$0.00
derived: sum of 4 quarters · filed 2019-03-12
2018-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$0.00
10-Q · filed 2018-08-09
$0.00
derived: sum of 3 quarters · filed 2019-03-12
$0.00
derived: sum of 4 quarters · filed 2019-03-12
2018-03-31$0.00
10-Q · filed 2018-05-10
$0.00
derived: sum of 2 quarters · filed 2019-03-12
$0.00
derived: sum of 3 quarters · filed 2019-03-12
$0.00
derived: sum of 4 quarters · filed 2019-03-12
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12
$0.00
derived: sum of 2 quarters · filed 2019-03-12
$0.00
derived: sum of 3 quarters · filed 2019-03-12
$0.00
10-K · filed 2019-03-12
2017-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08
$0.00
derived: sum of 2 quarters · filed 2018-11-08
$0.00
10-Q · filed 2018-11-08
2017-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
$0.00
10-Q · filed 2018-08-09
2017-03-31$0.00
10-Q · filed 2018-05-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
MetaVia Inc. (MTVA)United States$0.011B-0.65
Moleculin Biotech, Inc. (MBRX)United States$0.011B
Theriva Biologics, Inc. (TOVX)United States$0.011B
Azitra, Inc. (AZTR)United States$0.010B-0.81
Dare Bioscience, Inc. (DARE)United States$0.011B
Medicus Pharma Ltd. (MDCX)$0.010B
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
Aprea Therapeutics, Inc. (APRE)United States$0.010B-0.78
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92